Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ondansetron in Sepsis and Septic Shock
NCT05402553Phase 2Unknown
- Start
- Apr 2022
- Primary completion
- Jun 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of ondansetron in sepsis, septic shock. Status: unknown.
02
Drugs
ondansetron
03
Conditions
sepsisseptic shock
Beyond the preview
Go deeper on NCT05402553.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05402553.